SE8401748D0 - ANTIMYCOTIC MEDICINE IN THE FORM OF CREAM WITH HIGH-GRADUATE RELEASE OF ACTIVE SUBSTANCE - Google Patents

ANTIMYCOTIC MEDICINE IN THE FORM OF CREAM WITH HIGH-GRADUATE RELEASE OF ACTIVE SUBSTANCE

Info

Publication number
SE8401748D0
SE8401748D0 SE8401748A SE8401748A SE8401748D0 SE 8401748 D0 SE8401748 D0 SE 8401748D0 SE 8401748 A SE8401748 A SE 8401748A SE 8401748 A SE8401748 A SE 8401748A SE 8401748 D0 SE8401748 D0 SE 8401748D0
Authority
SE
Sweden
Prior art keywords
cream
graduate
release
active substance
antimycotic
Prior art date
Application number
SE8401748A
Other languages
Swedish (sv)
Other versions
SE8401748L (en
Inventor
K Adams
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE8401748D0 publication Critical patent/SE8401748D0/en
Publication of SE8401748L publication Critical patent/SE8401748L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to antimycotic cream compositions containing bifonazole as an antimycotic compound and including 5-25% by weight of a spreading agent, which is preferably selected from silicone oils, fatty acids, fatty acid esters, fatty alcohols and triglycerides.
SE8401748A 1983-03-30 1984-03-29 ANTIMYCOTIC MEDICINE IN THE FORM OF CREAM WITH HIGH-GRADUATE RELEASE OF ACTIVE SUBSTANCE SE8401748L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (en) 1983-03-30 1983-03-30 ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF CREAM

Publications (2)

Publication Number Publication Date
SE8401748D0 true SE8401748D0 (en) 1984-03-29
SE8401748L SE8401748L (en) 1984-10-01

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401748A SE8401748L (en) 1983-03-30 1984-03-29 ANTIMYCOTIC MEDICINE IN THE FORM OF CREAM WITH HIGH-GRADUATE RELEASE OF ACTIVE SUBSTANCE

Country Status (19)

Country Link
JP (1) JPS59184106A (en)
KR (1) KR840008284A (en)
AU (1) AU564956B2 (en)
BE (1) BE899278A (en)
CA (1) CA1212327A (en)
CH (1) CH660126A5 (en)
CY (1) CY1358A (en)
DE (1) DE3311701A1 (en)
ES (3) ES8503947A1 (en)
FR (1) FR2543435B1 (en)
GB (1) GB2137091B (en)
GR (1) GR81485B (en)
IT (1) IT1173761B (en)
KE (1) KE3704A (en)
LU (1) LU85271A1 (en)
PH (1) PH20420A (en)
PT (1) PT78313B (en)
SE (1) SE8401748L (en)
ZA (1) ZA842337B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
AU4399793A (en) * 1992-06-08 1994-01-04 Schering-Plough Healthcare Products, Inc. Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (en) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl- (1) -methanes and their salts, processes for their preparation and medicaments containing them
DE3045914A1 (en) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS
DE3045915A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS
DE3045913A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE
DE3106635A1 (en) * 1981-02-23 1982-09-09 Bayer Ag ANTIMYCOTIC AGENT WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF PEN

Also Published As

Publication number Publication date
ES530846A0 (en) 1985-04-16
KR840008284A (en) 1984-12-14
CH660126A5 (en) 1987-03-31
JPS59184106A (en) 1984-10-19
SE8401748L (en) 1984-10-01
ES539289A0 (en) 1985-11-16
BE899278A (en) 1984-10-01
ES8601693A1 (en) 1985-11-16
FR2543435A1 (en) 1984-10-05
LU85271A1 (en) 1984-11-14
KE3704A (en) 1987-03-27
ZA842337B (en) 1984-11-28
FR2543435B1 (en) 1988-06-17
PH20420A (en) 1987-01-05
GB2137091B (en) 1986-10-01
ES8503947A1 (en) 1985-04-16
PT78313A (en) 1984-04-01
AU564956B2 (en) 1987-09-03
CY1358A (en) 1987-08-07
IT8420303A0 (en) 1984-03-29
GB2137091A (en) 1984-10-03
IT1173761B (en) 1987-06-24
CA1212327A (en) 1986-10-07
GR81485B (en) 1984-12-11
ES8601692A1 (en) 1985-11-16
PT78313B (en) 1986-06-02
ES539290A0 (en) 1985-11-16
AU2623684A (en) 1984-10-04
GB8408067D0 (en) 1984-05-10
DE3311701A1 (en) 1984-10-04

Similar Documents

Publication Publication Date Title
MX9202638A (en) METHYL ESTERS OF SUBSTITUTED 2-PHENYL-3-METOXYACRYLIC ACID AND FUNGICIDAL COMPOSITIONS CONTAINING THEM.
FR2430410A1 (en) PHENETHANOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
ES2042723T3 (en) A PROCEDURE FOR PREPARING A GRANULAR PHARMACEUTICAL COMPOSITION.
IT7848604A0 (en) OXIMES DERIVED FROM 3-ACETOXYMETHYL 7-AMINO-THIAZOLYL-ACETAMMES OF CEPHALOSPORANIC ACID PROCEDURE FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THEM AS ACTIVE INGREDIENT
GB938828A (en) Improvements in or relating to pharmaceutical capsules comprising radioactive materials
ATE2650T1 (en) MEDICATED ANIMAL FOOD BASED ON LIVERMEAL AND PROCESS FOR ITS PRODUCTION.
UY26303A1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL AND TOPICAL ADMINISTRATION
IT1140529B (en) COMPOSITIONS TO BE USED AS COSMETICS AND PROCEDURE FOR THE PREPARATION OF THEIR ACTIVE INGREDIENTS
IT7947811A0 (en) RACEMIC SUBSTITUTED ZILIC OR OPTICALLY ACTIVE SUBSTITUTED ACETIC ACID ESTERS EQUIPPED WITH OPTICALLY ACTIVE PRO AND ALCOHOL BENPRIETIA' INSECTICIDE PROCEDURE FOR THEIR PRODUCTION AND INSECTICIDE COMPOSITIONS THAT CONTAIN THEM
NO891220L (en) COMPOSITION CONTAINING SALICYLIC ACID FOR TREATING LEPIDOSE.
SE8401748L (en) ANTIMYCOTIC MEDICINE IN THE FORM OF CREAM WITH HIGH-GRADUATE RELEASE OF ACTIVE SUBSTANCE
IL56822A (en) Pentafluorobenzyl esters of substituted cyclopropanecarboxilic acids,their preparation and their use as insecticides and acaricides
SE8506072D0 (en) STABILIZED WHEAT PEROXIDE COMPOSITION
JPS55133305A (en) Perfume controller
IT1140789B (en) SUBSTITUTED ESTERS OF CYCLOPROPANCARBOXYLIC ACID AND INSECTICIDE COMPOSITIONS THAT CONTAIN SAME AS ACTIVE INGREDIENT
JPS5549313A (en) Vitamin pharmaceutical and its preparation
JPS5753401A (en) Hair nourishing agent for promoting hair growth
BE877050A (en) USE OF ALIPHATIC HYDROXYCARBOXYLIC ACID ESTERS AS DEODORIZERS
IT8024165A0 (en) ESTERS OF DIALOGENOVINILCICLOPROPANCARBOXYLIC ACIDS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE TO FIGHT HARMFUL ORGANISMS AND ALSO ALPHA-HALOGENETHYL-3-PHENOXYBENZYL ALCOHOL.
SE8301565D0 (en) OIL SOLUBLE COMPOSITION CONTAINING FAT SOLUBLE VITAMIN
JPS55133306A (en) Perfume controller
NO912890D0 (en) PREPARATION CONTAINING SALICYLIC ACID FOR TREATMENT OF SKIN DISEASES WITH EXCELLENT.
KR840007522A (en) Fatty Acid-Containing Wool Composition
SU365147A1 (en) ) ALL-UNION
AR229086A1 (en) PROCEDURE TO PREPARE ESTERS DERIVED FROM ACID 2- (5,6-DIHYDRO-4H-1,3-TIAZIN-2-IL) -3-SUBSTITUTED-PROPIONIC AND PROCEDURE TO PREPARE AN AGRICULTURAL PESTICIDE COMPOSITION CONTAINING SUCH ESTERS